Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization is a dataset published in Translational Oncology (2021). On theSindex it has a DataRank of 1.7, placing it in the top 12.4% of the data-sharing corpus. It has been cited 73 times, with 41 citing works in its 1-hop citation network.
Ranks in the top 12% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
1.0
From 29 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 41 citers.
Bankhead-Coley Foundation
Grant: 09BB-22
US Army Medical Research and Materiel Command
Grant: 12-15479-01-07
US Army Medical Research and Materiel Command
Grant: W81XWH-08-2-0101
National Institutes of Health
Grant: R21CA101355
National Institutes of Health
Grant: R21CA135620
US Department of Defense
Grant: 170220051
National Institutes of Health
Grant: 5R21CA101355-02
Molecular Profiling to Predict Response to Chemotherapy
National Institutes of Health
Grant: 5R21CA135620-02
Validation of a Predictive Model of Clinical Response to Concurrent Radiochemothe
Medical Research and Materiel Command
FWCI
7.43
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
Additional file 1 of Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
Additional file 1 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 1 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 2 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 2 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 3 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 3 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 4 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 4 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 5 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 5 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 6 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 6 of Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
Additional file 1 of Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
Additional file 1 of Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy